Prime Medicine, Inc. (PRME)
4.255
+0.36
(+9.38%)
USD |
NASDAQ |
Nov 13, 16:00
4.255
0.00 (0.00%)
After-Hours: 19:59
Prime Medicine Price : 4.255 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 4.04 | 4.15 | 3.73 | 3.89 | 7.173M |
| Nov 11, 2026 | 3.89 | 4.35 | 3.80 | 4.30 | 12.85M |
| Nov 10, 2026 | 4.19 | 4.23 | 3.77 | 3.90 | 4.508M |
| Nov 09, 2026 | 4.68 | 4.71 | 4.22 | 4.30 | 3.509M |
| Nov 06, 2026 | 4.53 | 4.695 | 4.455 | 4.65 | 3.059M |
| Nov 05, 2026 | 4.86 | 4.91 | 4.300 | 4.45 | 4.748M |
| Nov 04, 2026 | 4.75 | 5.12 | 4.590 | 4.97 | 4.398M |
| Nov 03, 2026 | 4.50 | 4.885 | 4.435 | 4.55 | 4.121M |
| Nov 02, 2026 | 4.86 | 4.86 | 4.361 | 4.44 | 4.125M |
| Oct 30, 2026 | 5.02 | 5.20 | 4.675 | 4.72 | 6.569M |
| Oct 29, 2026 | 5.29 | 5.910 | 5.19 | 5.24 | 10.35M |
| Oct 28, 2026 | 4.24 | 5.43 | 4.11 | 5.36 | 15.20M |
| Oct 27, 2026 | 3.62 | 4.410 | 3.57 | 4.35 | 8.825M |
| Oct 26, 2026 | 3.68 | 3.70 | 3.57 | 3.61 | 2.512M |
| Oct 23, 2026 | 3.70 | 3.70 | 3.38 | 3.67 | 4.563M |
| Oct 22, 2026 | 3.68 | 3.920 | 3.62 | 3.73 | 4.658M |
| Oct 21, 2026 | 3.92 | 4.005 | 3.795 | 3.81 | 2.439M |
| Oct 20, 2026 | 3.75 | 4.05 | 3.73 | 3.92 | 3.695M |
| Oct 19, 2026 | 3.56 | 3.87 | 3.49 | 3.83 | 4.250M |
| Oct 16, 2026 | 3.55 | 3.605 | 3.41 | 3.47 | 4.393M |
| Oct 15, 2026 | 3.12 | 3.65 | 3.06 | 3.61 | 6.300M |
| Oct 14, 2026 | 3.21 | 3.22 | 3.045 | 3.13 | 4.237M |
| Oct 13, 2026 | 3.61 | 3.61 | 3.27 | 3.32 | 4.065M |
| Oct 12, 2026 | 3.95 | 3.965 | 3.58 | 3.61 | 3.138M |
| Oct 09, 2026 | 3.57 | 4.14 | 3.54 | 3.99 | 8.066M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 9.705 |
| Beam Therapeutics, Inc. | 22.85 |
| Twist Bioscience Corp. | 111.56 |
| Moderna, Inc. | 223.20 |
| Q32 Bio, Inc. | 8.72 |
Price Related Metrics
| PS Ratio | 181.60 |
| Price to Book Value | 19.32 |
| Earnings Yield | -25.51% |
| Market Cap | 769.04M |